Plontke Stefan K, Kösling Sabrina, Rahne Torsten
Department of Otorhinolaryngology, Head & Neck Surgery.
Department of Radiology, Martin Luther University Halle-Wittenberg, University Medicine Halle, Germany.
Otol Neurotol. 2018 Mar;39(3):365-371. doi: 10.1097/MAO.0000000000001696.
To describe the technique for surgical tumor removal, cochlear implant (CI) electrode placement and reconstruction of the surgical defect in patients with intracochlear schwannomas.
Retrospective case review.
Tertiary referral center.
Ten patients (five men, five women, mean age 48 ± 12 yr) with profound or severe to profound hearing loss due to intralabyrinthine schwannomas with intracochlear location.
Surgical tumor removal through extended round window approach, partial or subtotal cochleoectomy with or without labyrinthectomy and reconstruction of the surgical defect with cartilage, perichondrium or temporal muscle fascia, and bone pâté. Eight patients received a cochlear implant in the same procedure.
Retrospective evaluation of clinical outcome including safety aspects (adverse events) and audiological performance at early follow up in cases of cochlear implantation.
The tumor was successfully removed in all cases without macroscopic (operation microscope and endoscope) tumor remnants in the bony labyrinth apart from one case with initial transmodiolar growth. One patient needed revision surgery for labyrinthine fistula. At short-term follow up (3-month post-surgery), good hearing results with the cochlear implant were obtained in all but one patient with a word recognition score of 100% for numbers, and 64 ± 14% for monosyllables (at 65 dB SPL in quiet).
Surgical tumor removal and cochlear implantation is a promising treatment strategy in the management of intralabyrinthine schwannoma with intracochlear location, further extending the indication range for cochlear implantation. It is, however, of importance to observe the long-term outcome in these patients and to address challenges like follow up with magnetic resonance imaging.
描述切除耳蜗内神经鞘瘤患者肿瘤的手术技术、人工耳蜗(CI)电极置入及手术缺损的重建方法。
回顾性病例分析。
三级转诊中心。
10例因迷路内神经鞘瘤累及耳蜗而导致极重度或重度至极重度听力损失的患者(5例男性,5例女性,平均年龄48±12岁)。
通过扩大圆窗入路切除肿瘤,行部分或次全耳蜗切除术,可伴或不伴迷路切除术,并用软骨、骨膜或颞肌筋膜及骨糊重建手术缺损。8例患者在同一次手术中接受了人工耳蜗植入。
回顾性评估临床结果,包括安全性(不良事件)以及人工耳蜗植入病例早期随访时的听力学表现。
除1例最初经蜗轴生长的病例外,所有病例的肿瘤均成功切除,骨迷路内无肉眼可见(手术显微镜和内镜下)的肿瘤残留。1例患者因迷路瘘管需要再次手术。在短期随访(术后3个月)时,除1例患者外,所有接受人工耳蜗植入的患者均取得了良好的听力结果,数字的单词识别率为100%,单音节词的单词识别率为64±14%(在安静环境中65 dB SPL时)。
切除肿瘤并植入人工耳蜗是治疗累及耳蜗的迷路内神经鞘瘤的一种有前景的治疗策略,进一步扩大了人工耳蜗植入的适应证范围。然而,观察这些患者的长期预后并应对诸如磁共振成像随访等挑战非常重要。